New hope for improved antipsychotics
Efforts to develop more effective drugs for treating schizophrenia have received a significant boost with a groundbreaking study from the laboratory of Jones Parker at Northwestern University, published recently in Nature Neuroscience. Antipsychotic drugs, commonly prescribed for millions of people suffering from schizophrenia, often come with side effects and limited efficacy. However, this study offers